← Back to Search

Virtual Learning Collaborative (No ASR) for Acute Kidney Injury (IMPROVE-AKI Trial)

N/A
Waitlist Available
Led By Jeremiah R Brown, PhD
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 to 18 months after active interventions
Awards & highlights

IMPROVE-AKI Trial Summary

This trial is testing ways to prevent kidney damage during a cardiac catheterization procedure, which could help inform hospitals on how to better implement low-cost preventive strategies.

IMPROVE-AKI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 to 18 months after active interventions
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 to 18 months after active interventions for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acute Kidney Injury
Secondary outcome measures
Sustainability Measure

IMPROVE-AKI Trial Design

4Treatment groups
Active Control
Group I: Virtual Learning Collaborative (No ASR)Active Control2 Interventions
Virtual Learning Collaborative (VLC). Intervention: The VLC will be offered to 4 teams without automated surveillance reportingand will receive the AKI Prevention Toolkit plus monthly virtual training calls with the other VLC sites. Each participating site will be supported to establish a multidisciplinary team charged with continuously improving AKI, which will include interventional cardiologists, cardiac catheterization lab manager and technicians, nursing representatives from the intensive care unit and/or holding areas, cardiology administration, nephrology, and representation from the quality improvement department (VA Clinical Application Coordinator [CAC] and Systems Redesign).
Group II: Virtual Learning Collaborative with ASRActive Control3 Interventions
Virtual Learning Collaborative (VLC). Intervention: The VLC will be offered to 4 teams with automated surveillance reporting (ASR) and will receive the AKI Prevention Toolkit plus monthly virtual training calls with the other VLC sites with the and monthly ASR dashboard. Each participating site will be supported to establish a multidisciplinary team charged with continuously improving AKI, which will include interventional cardiologists, cardiac catheterization lab manager and technicians, nursing representatives from the intensive care unit and/or holding areas, cardiology administration, nephrology, and representation from the quality improvement department (VA Clinical Application Coordinator [CAC] and Systems Redesign).
Group III: Technical Assistance (No ASR)Active Control2 Interventions
Technical Assistance (TA). Intervention: TA will be offered to the 4 teams randomized to the TA condition without automated surveillance reporting and will receive the AKI Prevention Toolkit plus monthly technical calls independently
Group IV: Technical Assistance with ASRActive Control3 Interventions
Technical Assistance (TA). Intervention: TA will be offered to the 4 teams randomized to the TA condition with automated surveillance reporting (ASR) and will receive the AKI Prevention Toolkit plus monthly technical calls independently and monthly ASR dashboard.

Find a Location

Who is running the clinical trial?

Vanderbilt UniversityOTHER
703 Previous Clinical Trials
6,134,671 Total Patients Enrolled
8 Trials studying Acute Kidney Injury
31,331 Patients Enrolled for Acute Kidney Injury
Dartmouth-Hitchcock Medical CenterLead Sponsor
524 Previous Clinical Trials
2,534,663 Total Patients Enrolled
University of VermontOTHER
267 Previous Clinical Trials
3,735,065 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for participants to join this research endeavor?

"The clinical trial has been archived on the official website, as it was last updated on February 2nd 2022. Unfortunately, participants can no longer be enrolled in this specific study; however, there are 123 other trials actively seeking candidates at present."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
IMPROVE AKI Cluster-Randomized Trial
Jeremiah R. Brown 2019. "IMPROVE AKI Cluster-Randomized Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03556293.
~1554 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top